President Trump’s recently announced plan to lower prescription drug prices could benefit consumers in the short run, but it may end up hurting new drug development, experts say.
President Trump’s recently announced plan to lower prescription drug prices could benefit consumers in the short run, but it may end up hurting new drug development, experts say.
Companies value the benefits of agility. But they must do it strategically using five kinds of agility, writes Vivekin CEO Baba Prasad in his book, ‘Nimble.’
Despite its financial ills, Argentina may be on verge of an economic transformation thanks to a new generation of leaders who are embracing digital transformation, notes this opinion piece.
It’s hard to make better decisions faster when a company’s culture lacks trust and empathy, according to LinkedIn CEO Jeff Weiner.
Diverse teams make better decisions and are more resilient over time, says BlackRock’s Jonathan McBride.
The $16 billion transaction says a lot about India’s e-commerce ecosystem, writes former Snapdeal exec Rajat Kumar in this opinion piece.
Is it possible to end all epidemics? Harvard Medical School’s Jonathan Quick says there are steps public institutions can — but don’t — take to protect society.
New Wharton research examines which kinds of innovations spread more quickly than others in different networks, the role of influencers, and what that means for entrepreneurs.
The effectiveness of unconscious bias education hinges on a number of factors, including how it is presented, where and when it takes place, and whether an organization’s culture is conducive to having honest discussions.
Current Lauder student Annabell Hillenbrand (WG’19) shares about her experience taking part in a Lauder Intercultural Venture (LIV) to Madagascar. Direct Download
The Joseph H. Lauder Institute
256 South 37th street
2nd Floor
Philadelphia, PA 19104-6330